van Kooten C - Search Results

1

Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoids.

Gaykema LH, van Nieuwland RY, Dekkers MC, van Essen MF, Heidt S, Zaldumbide A, van den Berg CW, Rabelink TJ, van Kooten C. Gaykema LH, et al. Among authors: van essen mf, van den berg cw, van nieuwland ry, van kooten c. Front Immunol. 2023 Jan 12;13:1058763. doi: 10.3389/fimmu.2022.1058763. eCollection 2022. Front Immunol. 2023. PMID: 36713440 Free PMC article.

2

Interleukin-1 alpha enhances the biosynthesis of complement C3 and factor B by human kidney proximal tubular epithelial cells in vitro.

Gerritsma JS, Gerritsen AF, Van Kooten C, Van Es LA, Daha MR. Gerritsma JS, et al. Among authors: van es la, van kooten c. Mol Immunol. 1996 Jul;33(10):847-54. doi: 10.1016/0161-5890(96)84610-4. Mol Immunol. 1996. PMID: 8845016

3

Dendritic cells and complement: at the cross road of innate and adaptive immunity.

Castellano G, Woltman AM, Schena FP, Roos A, Daha MR, van Kooten C. Castellano G, et al. Among authors: van kooten c. Mol Immunol. 2004 Jun;41(2-3):133-40. doi: 10.1016/j.molimm.2004.03.018. Mol Immunol. 2004. PMID: 15159058 Review.

4

Stem cell therapy for glomerular disease.

Rabelink TJ, van Kooten C. Rabelink TJ, et al. Among authors: van kooten c. J Am Soc Nephrol. 2006 Aug;17(8):2086-8. doi: 10.1681/ASN.2006060599. Epub 2006 Jul 12. J Am Soc Nephrol. 2006. PMID: 16837640 No abstract available.

5

Complement activation by tubular cells is mediated by properdin binding.

Gaarkeuken H, Siezenga MA, Zuidwijk K, van Kooten C, Rabelink TJ, Daha MR, Berger SP. Gaarkeuken H, et al. Among authors: van kooten c. Am J Physiol Renal Physiol. 2008 Nov;295(5):F1397-403. doi: 10.1152/ajprenal.90313.2008. Epub 2008 Aug 27. Am J Physiol Renal Physiol. 2008. PMID: 18753294 Free article.

6

Complement production and regulation by dendritic cells: molecular switches between tolerance and immunity.

van Kooten C, Fiore N, Trouw LA, Csomor E, Xu W, Castellano G, Daha MR, Gelderman KA. van Kooten C, et al. Mol Immunol. 2008 Oct;45(16):4064-72. doi: 10.1016/j.molimm.2008.07.015. Mol Immunol. 2008. PMID: 18926283 Review.

7

Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin.

Heidt S, Roelen DL, Eijsink C, van Kooten C, Claas FH, Mulder A. Heidt S, et al. Among authors: van kooten c. Transplantation. 2008 Nov 15;86(9):1292-300. doi: 10.1097/TP.0b013e3181874a36. Transplantation. 2008. PMID: 19005412

8

Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.

Heidt S, Roelen DL, Eijsink C, Eikmans M, van Kooten C, Claas FH, Mulder A. Heidt S, et al. Among authors: van kooten c. Clin Exp Immunol. 2010 Feb;159(2):199-207. doi: 10.1111/j.1365-2249.2009.04051.x. Epub 2009 Nov 18. Clin Exp Immunol. 2010. PMID: 19922499 Free PMC article.

9

Natural IgM antibodies are involved in the activation of complement by hypoxic human tubular cells.

van der Pol P, Roos A, Berger SP, Daha MR, van Kooten C. van der Pol P, et al. Among authors: van kooten c. Am J Physiol Renal Physiol. 2011 Apr;300(4):F932-40. doi: 10.1152/ajprenal.00509.2010. Epub 2011 Feb 2. Am J Physiol Renal Physiol. 2011. PMID: 21289051 Free article.

10

Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation.

O'Flynn J, Flierman R, van der Pol P, Rops A, Satchell SC, Mathieson PW, van Kooten C, van der Vlag J, Berden JH, Daha MR. O'Flynn J, et al. Among authors: van kooten c, van der vlag j, van der pol p. Mol Immunol. 2011 Oct;49(1-2):75-83. doi: 10.1016/j.molimm.2011.07.020. Epub 2011 Aug 19. Mol Immunol. 2011. PMID: 21855148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

346 results

Search Page